New Drug May Bypass SARS-CoV-2 Blockade Of Innate Immune Response Scientists have identified a small molecule drug, diABZI, that potently inhibits infection in both cell cultures and mice models. Just one dose, delivered intranasally, could prevent and treat Covid-19.